MHRA - Medicines and Healthcare products Regulatory Agency

11/15/2024 | Press release | Distributed by Public on 11/15/2024 10:53

Consultation on the International Council for Harmonisation ICH E6 (R3) Guideline for Good Clinical Practice Annex-2

Open consultation

Consultation on the International Council for Harmonisation ICH E6 (R3) Guideline for Good Clinical Practice Annex-2

From: Medicines and Healthcare products Regulatory Agency Published 15 November 2024
Get emails about this page

Summary

The ICH Expert Working Group for ICH E6(R3) (EWG) has been updating the ICH E6(R2) GCP guideline. The MHRA represents the Pharmaceutical Inspection Co-operation Scheme (PIC/s) in the EWG.

This consultation closes at
11:59pm on 14 February 2025

Consultation description

The update of ICH E6 is to address the application of GCP to new trial designs, technological innovations and to strengthen a proportionate risk-based approach of its application for clinical trials of medicines to support regulatory and healthcare decision making.

This was set out in the ICH Reflection paper on Renovation of Good Clinical Practice and the ICH E6(R3) Concept Paper and a Business Plan was developed.

ICH E6(R3) has been restructured and is composed of an overarching principles section, Annex 1 (interventional clinical trials), Annex 2 (additional considerations for non-traditional interventional clinical trials), Glossary and Appendices.

The overarching principles, Annex 1, Glossary and Appendices will replace the current E6(R2) and were released for public consultation by ICH in May 2023.

The Annex 2 concept paper was endorsed by the ICH Management Committee on 28 April 2023 and was published on the ICH website.

Annex 2 has now reached Step 2b and is available for public consultation.

Ways to respond

Share this page

The following links open in a new tab

Updates to this page

Published 15 November 2024

Sign up for emails or print this page

Get emails about this page
Print this page

Explore the topic